[HTML][HTML] Feasibility of lung cancer screening in develo** countries: challenges, opportunities and way forward

A Shankar, D Saini, A Dubey, S Roy… - … lung cancer research, 2019 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of all cancer deaths worldwide, comprising 18.4% of all
cancer deaths. Low-dose computed tomography (LDCT) has shown mortality benefit in …

Lung cancer: prevalent trends & emerging concepts

PS Malik, V Raina - Indian Journal of Medical Research, 2015 - journals.lww.com
Lung cancer is one of the commonest cancers and cause of cancer related deaths all over
the world. It accounts for 13 per cent of all new cancer cases and 19 per cent of cancer …

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer

V Noronha, VM Patil, A Joshi, N Menon… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Standard first-line therapy for EGFR-mutant advanced non–small-cell lung
cancer (NSCLC) is an epidermal growth factor receptor (EGFR)–directed oral tyrosine …

[HTML][HTML] Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center

A Mohan, A Garg, A Gupta, S Sahu, C Choudhari… - Lung India, 2020 - journals.lww.com
Materials and Methods: Consecutive lung cancer patients were studied over a 10-year
period from January 2008 to March 2018 at the All India Institute of Medical Sciences, New …

Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity

A Chougule, K Prabhash, V Noronha, A Joshi… - PloS one, 2013 - journals.plos.org
Background During the past decade, the incidence of EGFR mutation has been shown to
vary across different ethnicities. It occurs at the rate of 10–15% in North Americans and …

Classification of histopathology images of lung cancer using convolutional neural network (CNN)

N Baranwal, P Doravari… - Disruptive Developments in …, 2022 - taylorfrancis.com
Cancer is the uncontrollable cell division of abnormal cells inside the human body, which
can spread to other body organs. It is a non-communicable diseases (NCDs), which account …

Uniqueness of lung cancer in Southeast Asia

V Noronha, A Budukh, P Chaturvedi, S Anne… - The Lancet Regional …, 2024 - thelancet.com
Lung cancer varies between Caucasians and Asians. There have been differences recorded
in the epidemiology, genomics, standard therapies and outcomes, with variations according …

Impact of the geriatric assessment on cancer-directed systemic therapy in older Indian persons with cancer: An observational study

V Noronha, A Rao, S Gattani… - Cancer Research …, 2022 - journals.lww.com
Background: The geriatric assessment is a multidimensional evaluation of an older person.
Globally, it is reported that geriatric assessments can lead to a change in the oncologic …

EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy

V Noronha, K Prabhash, A Thavamani, A Chougule… - PLoS …, 2013 - journals.plos.org
Screening for EGFR mutation is a key molecular test for management of lung cancer
patients. Outcome of patients with mutation receiving EGFR tyrosine kinase inhibitor is …

Making a case for cancer research in India

V Noronha - Cancer Research, Statistics, and Treatment, 2018 - journals.lww.com
72 Cancer Research, Statistics, and Treatment/Volume 1/Issue 1/January-June 2018 10
years. High‑impact work has been done by Dr. Dikshit from Tata Memorial Center (TMC) and …